Professor David Schellenberg BSc MB BS DTM&H MRCP PhD

Professor of Malaria & International Health


My first degrees are in clinical science and medicine from the University of London, followed by a DTM&H from Liverpool, MRCP in London and PhD from the University of Barcelona, Spain. I was based at the Ifakara Health Institute, Tanzania, between 1995-2001 then again 2004-2007, working on various descriptive and intervention studies relating to child health, especially malaria. I joined the School in 2003 to help build the IPTi Consortium, before returning to Tanzania in 2004 to work on a large-scale evaluation of the effectiveness of IPTi. I've been based in London since the end of 2007.




I supervise MSc (mainly PHDC), malaria study unit and PhD students, and lecture on the DTM&H, malaria study unit and various MSc courses.


Since 2009 I've been Director of the ACT Consortium (, answering key questions on malaria drug delivery. I am deputy director of the Malaria Capacity Development Consortium, which works to strengthen capacity for health research in Africa ( I support the Malaria Vaccine Initiative in the clinical evaluation of RTSs, the most advanced malaria vaccine candidate ( I worked extensively on Intermittent Preventive malaria Treatment for the control of malaria and anaemia in Infants (IPTi) ( Other interests include the evaluation of drug safety, the strengthening of health information systems, various methodological studies and micronutrient (iron and vitamin A) supplementation.

Research areas

  • Child health
  • Clinical trials
  • Public health


  • Epidemiology

Disease and Health Conditions

  • Malaria


  • Sub-Saharan Africa (developing only)


  • Afghanistan
  • Cambodia
  • Cameroon
  • Gabon
  • Ghana
  • India
  • Kenya
  • Malawi
  • Mozambique
  • Nigeria
  • Senegal
  • Tanzania
  • Uganda

Other interests

  • Access To Medicines
  • Anaemia
  • Cluster Randomised Trials
  • Cohort Studies
  • Community Based Treatment Of Fever
  • Effectiveness Evaluations
  • capacity building
Back to top